LINC 2020: 10 Presentations, 5 Countries, 4 Specialties, 1 Theme

If we were to summarize LINC 2020 in one sentiment it would be: compelling science with great clinicians from around the world, and Shockwave IVL was no exception.  We had the privilege of being spotlight-featured in ten physician presentations, representing four specialties, from five countries around the world.  Talk about an international meeting!  The speakers, featured in our IVL Booth Speaker Series, on the podium, and in the Main Arena, shared cases and first-hand experience of how IVL cracks calcium across a broad range of peripheral anatomy – from the iliacs to the ankles.

IVL in the Iliacs

On the Scientific Podium in the Main Arena, Prof Holden presented outcomes from his experience in Auckland on 16 IVL cases in the iliac artery, 4 to facilitate TEVAR/EVAR sheath delivery and 12 to facilitate revascularization in calcified, occlusive disease, with 100% acute procedural success, no embolic complications and no residual stenosis >20%.  Additionally, in the Speakers Corner, Dr Dixon shared his experience using IVL to safely treat iliac occlusive disease, with excellent results.


In our Shockwave IVL Booth Speaker Series, Dr Schwindt and Prof Holden discussed how they use the Shockwave M5 catheter to treat complex calcified iliacs, both for symptomatic occlusive disease as well as a means to enable the delivery of large bore EVAR and TEVAR devices.  Prof Holden spoke to IVL as a safe and effective treatment for complex calcified iliac access, saying, “Calcified iliac disease is certainly an impediment to EVAR and TEVAR and TAVI, and if we try and advance big caliber sheaths we can cause severe complications.  It’s also increasingly a problem in complex iliac occlusive disease and I think Intravascular Lithotripsy is becoming a more important adjunct to facilitate optimal results.”  Additionally, Dr Arne Schwindt succinctly articulated the same sentiment, that “IVL has the potential to make EVAR, TEVAR, and TAVI feasible for patients who otherwise cannot be treated because of their heavily diseased iliacs.”


LINC Andrew HoldenLINC Bill DixonLINC Arne Schwindt


IVL in the Tibials

In our Shockwave IVL Booth Speaker Series, Dr Adams talked about his unique experience treating calcified tibial disease with the Shockwave S4 catheter.  In his conclusion, Dr Adams summarized the benefit of the Shockwave S4 catheter, stating, “IVL is designed…to impact intimal and medial calcium with the hope of not only increasing the luminal gain but hopefully preventing adverse outcomes such as dissection and reducing recoil.”


LINC George Adams


IVL in the Femoropopliteal Segment

Dr Huasen and Dr Bisdas shared their broad experience across all lower limb procedures, especially highlighting treatment benefits in the femoropopliteal segment.  Dr Bisdas gave insight on when Shockwave IVL is definitely worth the cost, sharing, “There is a number of specific, unique applications that justify the cost of [IVL] treatment, that we are calling Standard of Care in the practice.  These are the so-called “no stent zones,” (CFA and popliteal artery), and also when we want to deliver a device with big profile through calcified iliac arteries, this is the best way to.”  Dr Lichtenberg finished off the Speaker Series with insights on the treatment of the CFA for patients that are not surgical candidates.  


On the Main Arena Scientific Podium, Prof Blessing showed outcomes in 15 patients where IVL + DCB was used in the CFA with a mean follow up of 9 months and Freedom from TLR of 87%.


Last but certainly not least, we were featured in a Live Case by Dr Chris Metzger, where he successfully treated a calcified left SFA and popliteal artery at Ballad Health System/Holston Valley Medical Center in Kingsport, TN in the United States.  Dr Metzger expertly demonstrated the simplicity of the IVL approach and demonstrated its utility in the standalone treatment of CFA disease, as well as to prepare a severely calcified popliteal for optimal Supera placement. 


LINC Bella HuasenLINC Theo Bisdas

LINC Michael LichtenbergProf Erwin Blessing

Chris Metzger


LINC 2020 provided excellent opportunities to learn from a diverse assembly of renowned experts, and hear a global perspective on how Shockwave IVL is changing practice around the world.


To learn more about Shockwave IVL for the treatment of calcified lesions, explore the Shockwave IVL Website for cases, clinical evidence, and resources.


Have questions or want to speak with an IVL representative?  Contact Us!


Lastly, don’t forget to follow us on Twitter at @ShockwaveIVL to stay up to date on the latest news.

Until next year….





Important Safety Information


Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.

Indication for Use – The Shockwave Medical Intravascular Lithotripsy (IVL) System is intended for lithotripsy-enhanced balloon dilatation of lesions, including calcified lesions, in the peripheral vasculature, including the iliac, femoral, ilio-femoral, popliteal, infra-popliteal, and renal arteries.  Not for use in the coronary or cerebral vasculature.


Contraindications – Do not use if unable to pass 0.014 guidewire across the lesion • Not intended for treatment of in-stent restenosis or in coronary, carotid, or cerebrovascular arteries.


Warnings – Only to be used by physicians who are familiar with interventional vascular procedures • Physicians must be trained prior to use of the device • Use the Generator in accordance with recommended settings as stated in the Operator’s Manual


Precautions – Use only the recommended balloon inflation medium • Appropriate anticoagulant therapy should be administered by the physician • Decision regarding use of distal protection should be made based on physician assessment of treatment lesion morphology


Adverse Effects – Possible adverse effects consistent with standard angioplasty include: • Access site complications • Allergy to contrast or blood thinners • Arterial bypass surgery • Bleeding complications • Death • Fracture of guidewire or device • Hypertension/Hypotension • Infection/sepsis • Placement of a stent • Renal failure • Shock/pulmonary edema • Target vessel stenosis or occlusion • Vascular complications. Risks unique to the device and its use: • Allergy to catheter material(s) • Device malfunction or failure • Excess heat at target site


Prior to use, please reference the Instructions for Use for more information on indications, contraindications, warnings, precautions, and adverse events.


false false LINC 2020: 10 Presentations, 5 Countries, 4 Specialties, 1 Theme Click Here To Read

To keep you apprised of the latest IVL news, education, and cases, please share your selected interests.